🇺🇸 ZTI-01 in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised ZTI-01 on 22 October 2025

Marketing authorisation

FDA — authorised 22 October 2025

Application: NDA212271
Marketing authorisation holder: MEITHEAL
Local brand name: CONTEPO
Indication: POWDER — INTRAVENOUS
Status: approved

Read official source →

Frequently asked questions

Is ZTI-01 approved in United States?

Yes. FDA authorised it on 22 October 2025.

Who is the marketing authorisation holder for ZTI-01 in United States?

MEITHEAL holds the US marketing authorisation.